Efficacy
SOLAR-1:
Pivotal randomized, double-blind, placebo-controlled, multicenter phase 3 trial in HR+/HER2-aBC 1 . A total of 572 patients were enrolled in the trial, including 341 patients with a PIK3CA mutation 1...
Did you mean: approved?
- Twitter Linkedin Facebook Pinterest Google plus
Safety profile
Predictable, manageable and reversible side effects while maintaining quality of life 6
As with any medication, side effects may occur when using the combination therapy Tafinlar® (dabrafenib) and Mekinist® (trametinib). The side...
Twitter Linkedin Facebook Pinterest Google plusEfficacy
1. Treatment guidelinesOver the past 10 years, the treatment landscape of SpA went through a substantial change, with an expansion of new therapies and new modes of action. Guidelines and recommendations have been developed to...
Twitter Linkedin Facebook Pinterest Google plusCAR-T talks: Tisagenlecleucel: a new potentially curative treatment option for patients with relapsed/refractory follicular lymphoma
While follicular lymphoma (FL) is an indolent form of non-Hodgkin lymphoma that is generally associated with long remissions, the disease remains incurable and for patients with relapsed/refractory (r/r) FL the prognosis is dismal. The recent...
Twitter Linkedin Facebook Pinterest Google plusProgram: The Academy
PROGRAM 2020: DATE TOPIC SPEAKERS 29 Sep 2020 20h-21h How to go back to business after COVID-19 and how to prepare your hospital for a second wave? The CEO’s vision...Twitter Linkedin Facebook Pinterest Google plus
×